Veracyte, headquartered in South San Francisco, develops diagnostic products for various cancers and employs 815 people. The company went public in 2013 and offers tests like Afirma and Decipher.
John Leite sold 7,411 shares of VCYT on 7 March at $31.96 per share, worth a total of $237K. They now own 105,260 VCYT shares, or a 7% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
